Mode
Text Size
Log in / Sign up

epratuzumab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of epratuzumab

7 trials tracked of epratuzumab: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 234 citations.

7Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 3 Phase 2 4
  1. Phase 3 Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus Completed · 234 cited
  2. Phase 3 Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) Completed · 234 cited
  3. Phase 3 Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus Completed
  4. Phase 2 Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma Completed
  5. Phase 2 S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Completed
  6. Phase 2 Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Completed
Show 1 more trials
  1. Phase 2 Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.